Kun He

Generating author description...

All published works

Action	Title	Year	Authors
+	Current Statistical Challenges in Oncology Clinical Trials in the Era of Targeted Therapy	2015	Rajeshwari Sridhara Kun He Lei Nie Yuan-Li Shen Shenghui Tang
+	Evaluation of Blinded Independent Central Review of Tumor Progression in Oncology Clinical Trials: A Meta-analysis	2012	Jenny J. Zhang Huanyu Chen Kun He Shenghui Tang Robert Justice Patricia Keegan Richard Pazdur Rajeshwari Sridhara

Common Coauthors

Coauthor	Papers Together
Shenghui Tang	2
Rajeshwari Sridhara	2
Yuan-Li Shen	1
Robert Justice	1
Patricia Keegan	1
Lei Nie	1
Huanyu Chen	1
Jenny J. Zhang	1
Richard Pazdur	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+ PDF Chat	Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials	2013	Scott Berry Kristine Broglio Susan Groshen Donald A. Berry	1
+ PDF Chat	A global logrank test for adaptive treatment strategies based on observational studies	2013	Zhiguo Li Marcia Valenstein P. Pfeiffer Dara Ganoczy	1
+	Is it time to abandon complete blinded independent central radiological evaluation of progression in registration trials?	2011	Francesco Pignatti Rob Hemmings Bertil Jönsson	1
+	How is retrospective independent review influenced by investigator‐introduced informative censoring: A quantitative approach	2011	Frank Fleischer Birgit Gaschler‐Markefski Erich Bluhmki	1
+	I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy	2009	AD Barker C C Sigman Kelloff Gj NM Hylton DA Berry L. Esserman	1
+	Ethical concerns about adaptive randomization	2015	Colin B. Begg	1
+	Marginal Structural Models and Causal Inference in Epidemiology	2000	James M. Robins Miguel A. Hernán Babette Brumback	1
+ PDF Chat	Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis	2014	Hajime Uno Brian Claggett Lü Tian Eisuke Inoue Paul Gallo Toshio Miyata Deborah Schrag Masahiro Takeuchi Yoshiaki Uyama Lihui Zhao	1
+	Adjusting for treatment switching in randomised controlled trials – A simulation study and a simplified two-stage method	2014	Nicholas Latimer Keith R. Abrams Paul C. Lambert Michael J. Crowther Allan Wailoo J.P. Morden RL Akehurst Michael J. Campbell	1
+	Cox Regression Methods for Two‐Stage Randomization Designs	2007	Yuliya Lokhnygina Jeffrey D. Helterbrand	1
+	Randomized Designs for Early Trials of New Cancer Treatments—An Overview	2000	Marc Buyse	1
+ PDF Chat	A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk	1988	Malcolm H. Ray	1
+ PDF Chat	An Audit Strategy for Progression-Free Survival	2011	Lori E. Dodd Edward L. Korn Boris Freidlin Robert J. Gray Suman Bhattacharya	1
+ PDF Chat	Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense?	2008	Lori E. Dodd Edward L. Korn Boris Freidlin C. Carl Jaffe Larry Rubinstein Janet Dancey Margaret Mooney	1
+ PDF Chat	Blinded Independent Central Review of the Progression-Free Survival Endpoint	2010	Ohad Amit Will Bushnell Lori E. Dodd Nancy Roach Daniel J. Sargent	1
+	Measurement error in the timing of events: effect on survival analyses in randomized clinical trials	2010	Edward L. Korn Lori E. Dodd Boris Freidlin	1
+	Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group	2011	A Stone William D. Bushnell Jon Denne Daniel J. Sargent Ohad Amit C. CHEN R. Bailey-Iacona Jeffrey D. Helterbrand Grant Williams	1
+	Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group	1998	Ralph B. D’Agostino	1
+	Recommendations for the assessment of progression in randomised cancer treatment trials	2008	Janet Dancey Lori E. Dodd Robert Ford Richard Kaplan Margaret Mooney Larry Rubinstein Lawrence H. Schwartz Lalitha Shankar P. Therasse	1
+ PDF Chat	Are outcome-adaptive allocation trials ethical?	2015	Spencer Phillips Hey Jonathan Kimmelman	1
+ PDF Chat	Weighted log-rank statistic to compare shared-path adaptive treatment strategies	2012	Kelley M. Kidwell Abdus S. Wahed	1
+ PDF Chat	Evaluation of Statistical Designs in Phase I Expansion Cohorts: The Dana-Farber/Harvard Cancer Center Experience	2014	Suzanne E. Dahlberg Geoffrey I. Shapiro Jeffrey W. Clark Bruce E. Johnson	1
+	Adjusted Kaplan–Meier estimator and log‐rank test with inverse probability of treatment weighting for survival data	2005	Jun Xie Chaofeng Liu	1
+ PDF Chat	Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trials	2009	Patricia A. Tang Gregory R. Pond Eric X. Chen	1
+ PDF Chat	Power and sample size calculation for log‐rank test with a time lag in treatment effect	2009	Daowen Zhang Hui Quan	1
+	Blinded independent central review of progression in cancer clinical trials: Results from a meta-analysis	2011	Ohad Amit Frank Mannino A Stone William D. Bushnell Jonathan Denne Jeffrey D. Helterbrand Hans-Ulrich Burger	1
+	Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study	2004	Jared Lunceford Marie Davidian	1
+	Relationship Between Progression-Free Survival and Overall Survival Benefit: A Simulation Study	2013	Lijun Zhang Chia‐Wen Ko Shenghui Tang Rajeshwari Sridhara	1
+	JP Journal of Biostatistics	2021	Félix Almendra‐Arao María del Rocío Reyes-Reyes Marian Catherin Díaz-Arias	1